Newborn Screening Tests Seminar
Category: editorial May 19, 2023. Credit:DESCRIPTION (EN)
Chief Executive Officer (CEO) of PT. SLX Global Healthcare K-Lab Indonesia Kim Myung Hun (right) talks with the Head of K-LAB Indonesia Pusparini during a joint seminar between Indonesia and Korea for Newborn Screening Tests held by K-LAB in Jakarta, Tuesday (16/5/2023) . New Born Screening Test (NST) is an examination to find out congenital metabolic disorders that can cause severe mental retardation to death. Through the NST examination, these abnormalities can be detected so that preventive and treatment measures can be taken as early as possible. (Courtesy of K-Lab Indonesia)
DESCRIPTION (ID)
Chief Executive Officer (CEO) PT. SLX Global Healthcare K-Lab Indonesia Kim Myung Hun (kanan) berbincang dengan Kepala K-LAB Indonesia Pusparini disela seminar kerja sama Indonesia dan Korea untuk Tes Skrining Bayi Baru Lahir yang digelar K-LAB di Jakarta, Selasa (16/5/2023). New Born Screeening Test (NST) merupakan pemeriksaan untuk mengetahui kelainan metabolisme bawaan yang dapat menyebabkan retardasi mental berat hingga kematian. Melalui pemeriksaan NST, kelainan tersebut dapat terdeteksi sehingga dapat dilakukan tindakan pencegahan dan pengobatan sedini mungkin. (Courtesy of K-Lab Indonesia)
